These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16928273)

  • 1. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
    Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
    BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
    Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y; España L; Mañas S; Fabra A; Sierra A
    Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.
    Kutuk O; Temel SG; Tolunay S; Basaga H
    Eur J Cancer; 2010 Sep; 46(13):2494-505. PubMed ID: 20619636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L; Yuan J; Stein R
    Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
    Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
    Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
    Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
    Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
    Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
    Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells].
    Ma C; Xie JW; Kuang AR; Huang R; Tang GS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):780-3. PubMed ID: 19950582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways.
    Tsujimoto Y; Shimizu S; Eguchi Y; Kamiike W; Matsuda H
    Leukemia; 1997 Apr; 11 Suppl 3():380-2. PubMed ID: 9209397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B; Safa AR
    Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
    Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bcl-2 proteins Noxa and Bcl-xL co-ordinately regulate oxidative stress-induced apoptosis.
    Eno CO; Zhao G; Olberding KE; Li C
    Biochem J; 2012 May; 444(1):69-78. PubMed ID: 22380599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.